Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 08, 2025
Symeres has appointed Gabriella Gentile as Chief Operating Officer (COO). This strategic addition to the executive team supports Symeres’ transatlantic growth ambitions, building upon its strong foundations in existing and novel modalities.
read more
Wednesday, November 07, 2018
Symphogen has selected TransPerfect’s Trial Interactive eTMF and supporting TMF services to centralize and streamline operations for current and future studies.
read more
Synairgen has announce that recruitment of 100 hospitalised patients in its clinical trial of SNG001 in COVID-19 patients has now been completed.
read more
Syndax and Nektar announced a non-exclusive, clinical collaboration to evaluate the safety and efficacy of NKTR-214 in combination with entinostat in patients with metastatic melanoma who have previously progressed on treatment with an anti-PD-1 ...
read more
Syneos Health® expanded its Decentralized Clinical Trial capabilities to include a dedicated Decentralized Clinical Trials Site Advocacy Group, continuing the momentum for Decentralized Solutions demonstrated by the recent acquisition of Illingworth ...
read more
Tuesday, January 05, 2021
Syneos Health announced the acquisition of Illingworth Research Group™, a provider of clinical research home health services.
read more
Syneos announced the acquisition of Kinapse, an advisory and operational solutions provider to the global life sciences industry, from Hg, a specialist investor based in the U.K.
read more
Thursday, October 07, 2021
Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of RxDataScience, a leading healthcare-focused data analytics, data management and artificial intelligence (AI) company....
read more
Tuesday, February 07, 2023
Syneos Health® a fully integrated biopharmaceutical solutions organization, announced a strategic partnership with Haystack Health, a Roivant Health portfolio company developing advanced Artificial Intelligence (AI) and Natural Language Processing (...
read more
Wednesday, March 22, 2023
Syneos Health® announced a strategic partnership with KX, maker of kdb, a series database and analytics engine.
read more
Tuesday, September 12, 2023
Syneos Health® a biopharmaceutical solutions organization, announced a strategic collaboration that will expand its relationship with Oracle. Using the Oracle Cerner Learning Health Network (LHN) and elements of Oracle’s suite of study startup ...
read more
Tuesday, February 28, 2023
Syneos Health® a fully integrated biopharmaceutical solutions organization, announced the launch of a Decentralized Clinical Trial (DCT) Site Network to drive appropriate DCT adoption and enable high quality delivery of DCTs and digital health ...
read more
Syneos Health™ has announced the appointment of Patrick Nealon as Executive Vice President and General Manager of Oncology Clinical Development.
read more
Syneos Health® announced the appointment of Michael Bonello as Chief Financial Officer, effective July 1, 2023. Stanford (Ben) Rudnick will continue to serve as Interim Chief Financial Officer until that time.
read more
Friday, November 15, 2019
Syneos Health announced the appointment of Bernadette Connaughton to the Company’s Board of Directors.
read more